Awen Oncology
2 known investors
Find your way into Awen Oncology
Awen Oncology is a drug discovery company developing first-in-class oncology therapeutics that target cancer-specific proteins found only in tumor cells, aiming for treatments with improved efficacy and fewer side effects. It combines high-throughput cell and molecular biology with computational techniques to identify novel therapeutic targets for cancer patients.
Founders & leadership
Investors · 2
In the news
Frequently asked questions
- What does Awen Oncology do?
- Awen Oncology is a drug discovery company developing first-in-class oncology therapeutics that target cancer-specific proteins found only in tumor cells, aiming for treatments with improved efficacy and fewer side effects. It combines high-throughput cell and molecular biology with computational techniques to identify novel therapeutic targets for cancer patients.
- Who founded Awen Oncology?
- Awen Oncology was founded by Prof. Andrea Brancale, Dr. Ramsay McFarlane, Dr. Jane Wakeman.
- Who are Awen Oncology's investors?
- Awen Oncology's investors include Start Codon, Development Bank of Wales.